Callisto Pharmaceuticals' IPO

Callisto Pharmaceuticals raised a round of funding on August 12, 2004. Investors include Public.

Callisto Pharmaceuticals is a biopharmaceutical company focused on the development of drugs to treat multiple myeloma (an incurable blood cancer that invades and proliferates in bone marrow), and oste…

Articles about Callisto Pharmaceuticals' IPO: